Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework
Raymond Li, Kate Curtis, Connie Van, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 7, pp. 1165-1175
Open Access | Times Cited: 17

Showing 17 citing articles:

A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting
Raymond Li, Kate Curtis, Syed Tabish R. Zaidi, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 9, pp. 1193-1204
Closed Access | Times Cited: 17
Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings
Pallavi Pradhan, Maude Lavallée, Samuel Akinola, et al.
Journal of Applied Biomedicine (2023) Vol. 21, Iss. 2, pp. 59-66
Open Access | Times Cited: 8
Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework
Joel Fossouo Tagne, Reginald Amin Yakob, Rachael McDonald, et al.
Interactive Journal of Medical Research (2022) Vol. 11, Iss. 2, pp. e40597-e40597
Open Access | Times Cited: 11
Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy
Joel Fossouo Tagne, Reginald Amin Yakob, Rachael McDonald, et al.
JMIR Human Factors (2023) Vol. 10, pp. e43529-e43529
Open Access | Times Cited: 4
An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta
Elisa Curtolo, Benjamin Micallef, Janis Vella Szijj, et al.
International Journal of Risk & Safety in Medicine (2024) Vol. 35, Iss. 3, pp. 271-286
Closed Access | Times Cited: 1
Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines
Gaetano La Mantia, Fortunato Buttacavoli, Vera Panzarella, et al.
Oral (2023) Vol. 3, Iss. 3, pp. 411-419
Open Access | Times Cited: 2
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
Annamaria Mascolo, Concetta Rafaniello, Gabriella di Mauro, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Retrospective Analysis of Patient-Reported Adverse Drug Reactions in an Italian Allergy Unit: ALLERG-RAF Study
Andrea Abate, Elisa Rossini, Mariangela Tamburello, et al.
Pharmacology (2024) Vol. 109, Iss. 3, pp. 129-137
Closed Access
Adverse medication reactions: raising a red flag locally, sharing lessons globally, improving safety and quality in health care
Linda V Graudins
International Journal for Quality in Health Care (2024) Vol. 37, Iss. 1
Closed Access
Pharmacovigilance Practices by Healthcare Providers in Oncology: A Cross-Sectional Study
Hadeel Alkofide, Haya M. Almalag, Mashael Alromaih, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 683-683
Open Access
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019–2021)
Liberata Sportiello, Gaetano La Mantia, Vera Panzarella, et al.
Oral Diseases (2024)
Open Access
Intelligent wearable-assisted digital healthcare industry 5.0
Vrutti Tandel, Aparna Kumari, Sudeep Tanwar, et al.
Artificial Intelligence in Medicine (2024) Vol. 157, pp. 103000-103000
Closed Access
Pharmacovigilance in Australia – how do adverse event reports from clinicians contribute to medicine and vaccine safety?
Deborah Greenbaum, Stephanie G. Cheung, Claire Turner, et al.
Australian Prescriber (2024) Vol. 47, Iss. 6, pp. 186-191
Closed Access
Adverse drug reaction reporting by healthcare providers in sub-Saharan Africa: A scoping review of the challenges faced and the strategies to address the challenges
Enos Moyo, Perseverance Moyo, Derek Mangoya, et al.
International Journal of Africa Nursing Sciences (2023) Vol. 19, pp. 100639-100639
Open Access | Times Cited: 1
Adverse events and drug–drug interactions of sodium glucose co-transporter 2 inhibitors in patients treated for heart failure
Claudia Stöllberger, Josef Finsterer, Birke Schneider
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 11, pp. 803-816
Closed Access | Times Cited: 1
Barriers to ADR reporting by hospital staff

Reactions Weekly (2022) Vol. 1905, Iss. 1, pp. 4-4
Closed Access
Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy (Preprint)
Joel Fossouo Tagne, Reginald Amin Yakob, Rachael McDonald, et al.
(2022)
Open Access
Page 1

Scroll to top